Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection - Concepedia

Concepedia

Publication | Open Access

Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection

DOI Full Paper Access

27

Citations

14

References

2020

Year

Eli Zuckerman, Julio Gutiérrez, Douglas E. Dylla, Victor de Lédinghen, Andrew J. Muir, Michael Gschwantler, Massimo Puoti, Florin Alexandru Căruntu, Jihad Slim, Frederik Nevens,

Clinical Gastroenterology and Hepatology

References

	Year	Citations

Page 1